ADCT ADC Therapeutics SA Common Shares
$3,23
Fiyat · May 20, 2026
Temel veriler itibarıyla May 4, 2026
52 Haftlık Aralık
$2–$5
44% of range
Analist Derecelendirmesi
BUY
12 analysts
Fiyat Hedefi
$8
+154% upside
P/E (TTM)
-3.2
ROE
74.1%
Net Kâr Marjı
-175.3%
ADCT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$3.23
Piyasa Değeri
$444M
P/E (TTM)
-3.2
EPS (TTM)
$-1.12
Gelir (TTM)
$81M
Temettü Verimi
—
ROE
74.1%
D/E Borç/Özsermaye
-0.0
52 Haftlık Aralık
$2 – $5
ADCT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$81M
2022-12-31
→
2025-12-31
Hisse Başına Kâr
$-1.12
2022-12-31
→
2025-12-31
Serbest Nakit Akışı
$-141M
2023-12-31
→
2025-12-31
Marjlar
-175.3%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
ADCT
Akran Ortalaması
P/E (TTM)
-3.2
—
P/S (TTM) (F/S (TTM))
5.5
56.3
P/B (F/D)
-2.4
2.6
EV / EBITDA
-1.5
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
-3.1
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
ADCT
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-149.3%
—
Net Profit Margin (Net Kâr Marjı)
-175.3%
-1273.7%
ROA
-44.2%
-44.7%
ROE
74.1%
-83.5%
ROIC
66.9%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
ADCT
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
-0.0
0.0
Current Ratio (Cari Oran)
4.4
4.1
Quick Ratio (Cari Oran)
3.7
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
ADCT
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
14.8%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
-27.1%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
ADCT
Akran Ortalaması
ADCT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
12 analist
- Güçlü Al 5 41,7%
- Al 6 50,0%
- Tut 1 8,3%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
5 analist · 2026-05-14
Medyan
$8.00
← Tüm hedeflerin altında
$3.23
Düşük
$6.00
Yüksek
$10.00
Medyan hedef
$8.00
+147,7%
Ortalama hedef
$8.20
+153,9%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.11%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.13 | $-0.22 | 0.09% |
| 31 Aralık 2025 | $-0.04 | $-0.27 | 0.23% |
| 30 Eylül 2025 | $-0.30 | $-0.37 | 0.07% |
| 30 Haziran 2025 | $-0.38 | $-0.48 | 0.10% |
| 31 Mart 2025 | $-0.36 | $-0.41 | 0.05% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ADCT | $444M | -3.2 | 14.8% | -175.3% | 74.1% | — |
| CRSP | $5.03B | -8.1 | -90.6% | -16569.8% | -32.0% | — |
| MLTX | — | -3.7 | — | — | -60.5% | — |
| ACIU | — | — | — | — | — | — |
| NCEL | — | — | — | — | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $81M | $71M | $70M | $210M | |
| Cost of Revenue | $6M | $6M | $3M | $3M | |
| R&D Expense | $104M | $110M | $127M | $186M | |
| SG&A Expense | $37M | $42M | $48M | $74M | |
| Operating Expenses | $203M | $201M | $236M | $333M | |
| Operating Income | $-121M | $-131M | $-166M | $-123M | |
| Interest Expense | · | $50M | $46M | $37M | |
| Interest Income | $9M | $12M | $11M | $3M | |
| Other Non-op | $23M | $12M | $6M | $53M | |
| Pretax Income | $-142M | $-156M | $-195M | $-147M | |
| Income Tax | $1M | $166.0K | $39M | $227.0K | |
| Net Income | $-143M | $-158M | $-240M | $-157M | |
| EPS (Basic) | $-1.12 | $-1.62 | $-2.94 | $-2.01 | |
| EPS (Diluted) | $-1.12 | $-1.62 | $-2.94 | $-2.01 | |
| Shares (Basic) | 127,067,540 | 97,159,966 | 81,712,166 | 78,152,964 | |
| Shares (Diluted) | 127,067,540 | 97,159,966 | 81,712,166 | 78,152,964 | |
| EBITDA | $-121M | $-131M | $-166M | · |
Bilanço 26
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $261M | $251M | $279M | $326M | |
| Inventory | $4M | $2M | $16M | $12M | |
| Prepaid Expense | $6M | $8M | $10M | $23M | |
| Other Current Assets | $6M | $9M | $6M | · | |
| Current Assets | $306M | $291M | $336M | $435M | |
| PP&E (Net) | $0 | $5M | $6M | $3M | |
| PP&E (Gross) | $1M | $10M | $10M | $7M | |
| Accum. Depreciation | $1M | $5M | $4M | $3M | |
| Other Non-current Assets | $1M | $1M | $711.0K | $902.0K | |
| Total Assets | $323M | $322M | $355M | $491M | |
| Accounts Payable | $9M | $18M | $16M | $12M | |
| Accrued Liabilities | $58M | $62M | $52M | $68M | |
| Current Liabilities | $70M | $80M | $68M | $82M | |
| Capital Leases | $1M | $8M | $10M | $7M | |
| Deferred Tax | $789.0K | $2M | $1M | $4M | |
| Other Non-current Liabilities | $3M | $2M | $9M | $838.0K | |
| Total Liabilities | $509M | $525M | $503M | $411M | |
| Total Debt | $3M | · | · | · | |
| Common Stock | $11M | $8M | $7M | $7M | |
| Paid-in Capital | $1.44B | $1.28B | $1.18B | $1.17B | |
| Retained Earnings | $-1.64B | $-1.49B | $-1.34B | $-1.10B | |
| Treasury Stock | $205.0K | $220.0K | $541.0K | $679.0K | |
| AOCI | $-517.0K | $-1M | $-93.0K | $2M | |
| Stockholders' Equity | $-186M | $-203M | $-148M | $79M | |
| Liabilities + Equity | $323M | $322M | $355M | $491M | |
| Shares Outstanding | 125,748,762 | 101,606,376 | 89,041,946 | 89,041,946 |
Nakit Akışı 11
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $7M | $7M | $13M | $49M | |
| Deferred Tax | $0 | $0 | $37M | $-2M | |
| Operating Cash Flow | $-141M | $-124M | $-119M | $-138M | |
| CapEx | $264.0K | $867.0K | $3M | $687.0K | |
| Investing Cash Flow | $395.0K | $-867.0K | $-3M | $-687.0K | |
| Stock Issued | $86M | $61M | $0 | · | |
| Net Stock Activity | $86M | $61M | · | · | |
| Financing Cash Flow | $151M | $97M | $74M | $-897.0K | |
| Taxes Paid | $-100.0K | $-900.0K | · | · | |
| Free Cash Flow | $-141M | $-125M | $-122M | · | |
| Levered FCF | · | $-175M | $-177M | · |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -149.3% | -184.4% | -238.6% | · | |
| Net Margin | -175.3% | -222.8% | -345.1% | · | |
| Pretax Margin | -174.1% | -220.4% | -280.9% | · | |
| EBITDA Margin | -149.3% | -184.4% | -238.6% | · | |
| ROA | -44.2% | -46.7% | -56.8% | · | |
| ROE | 74.1% | 84.3% | 225.9% | · | |
| ROIC | 66.9% | 64.5% | 134.4% | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 4.4 | 3.8 | 5.0 | · | |
| Quick Ratio | 3.7 | 3.1 | 4.1 | · | |
| Debt / Equity | -0.0 | · | · | · | |
| Interest Coverage | · | -2.6 | -3.6 | · |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.2 | · | |
| Inventory Turnover | 1.8 | 0.3 | 0.2 | · |
Büyüme Oranları 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 14.8% | 1.8% | -66.9% | · | |
| Revenue CAGR 3Y | -27.1% | · | · | · |
Değerleme (TTM) 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $81M | $71M | $70M | · | |
| Net Income TTM | $-143M | $-158M | $-240M | · | |
| Market Cap | $444M | $197M | $137M | · | |
| Enterprise Value | $186M | · | · | · | |
| P/E | -3.2 | -1.2 | -0.6 | · | |
| P/S | 5.5 | 2.8 | 2.0 | · | |
| P/B | -2.4 | -1.0 | -0.9 | · | |
| P / Cash Flow | -3.1 | -1.6 | -1.2 | · | |
| P / FCF | -3.1 | -1.6 | -1.1 | · | |
| EV / EBITDA | -1.5 | · | · | · | |
| EV / FCF | -1.3 | · | · | · | |
| EV / Revenue | 2.3 | · | · | · | |
| Earnings Yield | -31.7% | -81.4% | -177.1% | · |
Gelir Tablosu 16
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21M | $23M | $16M | $19M | $23M | $17M | $18M | $17M | $18M | $17M | $14M | $19M | $19M | |
| R&D Expense | $20M | $18M | $27M | $30M | $29M | $27M | $33M | $24M | $26M | $30M | $27M | $31M | $38M | |
| SG&A Expense | $10M | $9M | $8M | $9M | $10M | $10M | $10M | $10M | $12M | $11M | $10M | $12M | $16M | |
| Operating Expenses | $46M | $41M | $47M | $63M | $51M | $49M | $54M | $46M | $52M | $57M | $51M | $59M | $69M | |
| Operating Income | $-25M | $-18M | $-31M | $-44M | $-28M | $-32M | $-36M | $-29M | $-34M | $-40M | $-36M | $-40M | $-50M | |
| Interest Expense | · | · | · | · | $12M | · | $13M | $13M | $12M | $13M | $13M | $10M | $10M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Other Non-op | $3M | $22M | $925.0K | $-182.0K | $203.0K | $11M | $2M | $3M | $-3M | $10M | $860.0K | $-5M | $833.0K | |
| Pretax Income | $-33M | $-7M | $-41M | $-55M | $-38M | $-31M | $-44M | $-36M | $-46M | $-40M | $-45M | $-53M | $-57M | |
| Income Tax | $0 | $-404.0K | $0 | $1M | $165.0K | $-321.0K | $90.0K | $234.0K | $163.0K | $43M | $-85.0K | $-4M | $518.0K | |
| Net Income | $-33M | $-6M | $-41M | $-57M | $-39M | $-31M | $-44M | $-37M | $-47M | $-85M | $-47M | $-49M | $-59M | |
| EPS (Basic) | $-0.21 | $0.04 | $-0.30 | $-0.50 | $-0.36 | $-0.26 | $-0.42 | $-0.38 | $-0.56 | $-1.04 | $-0.57 | $-0.60 | $-0.73 | |
| EPS (Diluted) | $-0.21 | $0.04 | $-0.30 | $-0.50 | $-0.36 | $-0.26 | $-0.42 | $-0.38 | $-0.56 | $-1.04 | $-0.57 | $-0.60 | $-0.73 | |
| Shares (Basic) | 154,142,347 | -230,324,726 | 136,446,534 | 113,743,358 | 107,202,374 | -185,908,478 | 104,824,877 | 95,691,245 | 82,552,322 | -162,821,578 | 82,256,847 | 81,471,127 | 80,805,770 | |
| Shares (Diluted) | 154,142,347 | -230,324,726 | 136,446,534 | 113,743,358 | 107,202,374 | -185,908,478 | 104,824,877 | 95,691,245 | 82,552,322 | -162,821,578 | 82,256,847 | 81,471,127 | 80,805,770 | |
| EBITDA | $-25M | · | $-31M | $-44M | $-28M | · | $-36M | $-29M | $-34M | · | · | · | · |
Bilanço 26
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $231M | $261M | $235M | $265M | $195M | $251M | $274M | $300M | $234M | $279M | · | · | · | |
| Inventory | $5M | $4M | $18M | $18M | $17M | $2M | $16M | $15M | $16M | $16M | · | · | · | |
| Prepaid Expense | $6M | $6M | $6M | $5M | $7M | $8M | $19M | $17M | $17M | $10M | · | · | · | |
| Other Current Assets | $4M | $6M | $6M | $6M | $7M | $9M | · | · | · | $6M | · | · | · | |
| Current Assets | $277M | $306M | $287M | $319M | $258M | $291M | $333M | $355M | $290M | $336M | · | · | · | |
| PP&E (Net) | · | $0 | $0 | $1.0K | $5M | $5M | $6M | $5M | $6M | $6M | · | · | · | |
| PP&E (Gross) | · | $1M | $6M | $6M | $11M | $10M | $11M | $10M | $10M | $10M | · | · | · | |
| Accum. Depreciation | · | $1M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $4M | · | · | · | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $992.0K | $986.0K | $711.0K | · | · | · | |
| Total Assets | $291M | $323M | $290M | $322M | $273M | $322M | $349M | $372M | $308M | $355M | · | · | · | |
| Accounts Payable | $5M | $9M | $8M | $10M | $16M | $18M | $14M | $11M | $14M | $16M | · | · | · | |
| Accrued Liabilities | $58M | $58M | $54M | $55M | $42M | $62M | $53M | $47M | $49M | $52M | · | · | · | |
| Current Liabilities | $68M | $70M | $62M | $65M | $58M | $80M | $68M | $58M | $63M | $68M | · | · | · | |
| Capital Leases | $991.0K | $1M | $1M | $1M | $8M | $8M | $9M | $9M | $10M | $10M | · | · | · | |
| Deferred Tax | · | $789.0K | · | · | · | $2M | · | · | · | $1M | · | · | · | |
| Other Non-current Liabilities | $5M | $3M | $9M | $7M | $4M | $2M | $8M | $7M | $7M | $9M | · | · | · | |
| Total Liabilities | $508M | $509M | $528M | $521M | $511M | $525M | $521M | $503M | $502M | $503M | · | · | · | |
| Total Debt | $5M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $11M | $11M | $10M | $10M | $8M | $8M | $8M | $8M | $7M | $7M | · | · | · | |
| Paid-in Capital | $1.44B | $1.44B | $1.38B | $1.38B | $1.29B | $1.28B | $1.28B | $1.28B | $1.18B | $1.18B | · | · | · | |
| Retained Earnings | $-1.67B | $-1.64B | $-1.63B | $-1.59B | $-1.53B | $-1.49B | $-1.46B | $-1.42B | $-1.38B | $-1.34B | · | · | · | |
| Treasury Stock | $205.0K | $205.0K | $205.0K | $207.0K | $207.0K | $220.0K | $222.0K | $239.0K | $502.0K | $541.0K | · | · | · | |
| AOCI | $-802.0K | $-517.0K | $-702.0K | $-388.0K | $-1M | $-1M | $203.0K | $-338.0K | $-201.0K | $-93.0K | · | · | · | |
| Stockholders' Equity | $-216M | $-186M | $-238M | $-199M | $-238M | $-203M | $-172M | $-132M | $-194M | $-148M | · | · | · | |
| Liabilities + Equity | $291M | $323M | $290M | $322M | $273M | $322M | $349M | $372M | $308M | $355M | · | · | · | |
| Shares Outstanding | 127,165,116 | 125,748,762 | 112,626,731 | 112,499,083 | 99,178,286 | 98,861,402 | 96,687,985 | 96,469,641 | 82,777,226 | 82,293,137 | · | · | · |
Nakit Akışı 9
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $673.0K | $2M | $2M | $2M | $2M | $3M | $2M | $158.0K | $2M | $2M | $1M | $8M | |
| Operating Cash Flow | $-30M | $-31M | $-30M | $-24M | $-56M | $-22M | $-25M | $-33M | $-44M | $-32M | $-37M | $-35M | $-15M | |
| CapEx | $32.0K | $0 | $0 | $0 | $264.0K | $90.0K | $216.0K | $30.0K | $531.0K | $327.0K | $661.0K | $1M | $1M | |
| Investing Cash Flow | $-32.0K | $659.0K | $0 | $0 | $-264.0K | $-90.0K | $-216.0K | $-30.0K | $-531.0K | $-327.0K | $-661.0K | $-1M | $-1M | |
| Stock Issued | $-20.0K | $44M | $-479.0K | $43M | $0 | $0 | $-1M | · | · | $0 | $0 | · | · | |
| Net Stock Activity | $-20.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-583.0K | $57M | $-198.0K | $94M | $271.0K | $-1M | $-879.0K | $99M | $356.0K | $-1.0K | $349.0K | $73M | $425.0K | |
| Free Cash Flow | $-30M | · | · | · | $-57M | · | · | · | $-45M | · | · | · | · | |
| Levered FCF | · | · | · | · | $-69M | · | · | · | $-57M | · | · | · | · |
Kârlılık 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -121.1% | · | -188.5% | -234.3% | -123.6% | · | -192.6% | -166.8% | -186.2% | · | · | · | · | |
| Net Margin | -158.1% | · | -249.4% | -300.7% | -167.6% | · | -238.1% | -209.9% | -258.2% | · | · | · | · | |
| Pretax Margin | -158.1% | · | -249.4% | -294.0% | -166.9% | · | -236.2% | -205.1% | -253.4% | · | · | · | · | |
| EBITDA Margin | -121.1% | · | -188.5% | -234.3% | -123.6% | · | -192.6% | -166.8% | -186.2% | · | · | · | · | |
| ROA | -11.7% | · | -12.8% | -16.3% | -13.3% | · | -25.2% | -19.7% | -30.3% | · | · | · | · | |
| ROE | 14.5% | · | 20.0% | 34.2% | 17.8% | · | 51.1% | 55.5% | 47.9% | · | · | · | · | |
| ROIC | 11.9% | · | 13.0% | 22.7% | 12.0% | · | 20.7% | 22.2% | 17.3% | · | · | · | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.1 | · | 4.6 | 4.9 | 4.5 | · | 4.9 | 6.2 | 4.6 | · | · | · | · | |
| Quick Ratio | 3.4 | · | 3.8 | 4.1 | 3.4 | · | 4.1 | 5.2 | 3.7 | · | · | · | · | |
| Debt / Equity | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | -2.3 | · | -2.7 | -2.3 | -2.7 | · | · | · | · |
Verimlilik 1
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · |
Değerleme (TTM) 13
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $79M | · | $77M | $78M | $77M | · | $68M | $69M | $71M | · | · | · | · | |
| Net Income TTM | $-169M | · | $-180M | $-176M | $-166M | · | $-174M | $-179M | $-202M | · | · | · | · | |
| Market Cap | $477M | · | $451M | $301M | $140M | · | $305M | $305M | $372M | · | · | · | · | |
| Enterprise Value | $250M | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -2.7 | · | -2.5 | -1.6 | -0.8 | · | -1.6 | -1.5 | -1.8 | · | · | · | · | |
| P/S | 6.0 | · | 5.9 | 3.9 | 1.8 | · | 4.5 | 4.4 | 5.2 | · | · | · | · | |
| P/B | -2.2 | · | -1.9 | -1.5 | -0.6 | · | -1.8 | -2.3 | -1.9 | · | · | · | · | |
| P / Cash Flow | -16.1 | · | · | · | -2.5 | · | · | · | -8.4 | · | · | · | · | |
| P / FCF | -16.0 | · | · | · | -2.5 | · | · | · | -8.3 | · | · | · | · | |
| EV / EBITDA | -9.9 | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | -8.4 | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 3.2 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -36.5% | · | -39.5% | -61.9% | -122.0% | · | -61.3% | -66.8% | -54.8% | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Gelir | $81M | $71M | $70M | $210M |
| Faaliyet Kâr Marjı % | -149.3% | -184.4% | -238.6% | — |
| Net Gelir | $-143M | $-158M | $-240M | $-157M |
| Seyreltilmiş Hisse Başı Kâr | $-1.12 | $-1.62 | $-2.94 | $-2.01 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Borç / Öz Sermaye | -0.0 | — | — | — |
| Cari Oran | 4.4 | 3.8 | 5.0 | — |
| Cari Oran | 3.7 | 3.1 | 4.1 | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Serbest Nakit Akışı | $-141M | $-125M | $-122M | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.